Nataliya Romanyuk

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

Adrian C. Newland, Blanca Sánchez‐González, László Rejtő et al. · American Journal of Hematology · 2019 · 173 citations · Full text

A Comparative Study of Three Different Types of Stem Cells for Treatment of Rat Spinal Cord Injury

Jiří Růžička, Lucia Machová Urdzíková, John L. Gillick et al. · Cell Transplantation · 2016 · 123 citations · Full text

Beneficial Effect of Human Induced Pluripotent Stem Cell-Derived Neural Precursors in Spinal Cord Injury Repair

Nataliya Romanyuk, Takashi Amemori, Karolína Turnovcová et al. · Cell Transplantation · 2015 · 113 citations · Full text

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa et al. · The Lancet · 2023 · 77 citations · Full text

Thrombopoiesis, Autoimmune Disease, Blood Platelet +11

Human Induced Pluripotent Stem Cells Improve Stroke Outcome and Reduce Secondary Degeneration in the Recipient Brain

Jérôme Polentes, Pavla Jendelová, Michel Cailleret et al. · Cell Transplantation · 2012 · 75 citations · Full text

Host Substantia Nigra, Reduce Secondary Degeneration, Regenerative Medicine +25